myLaminin Perspectives

This paper advocates a fundamental rethinking of how Higher Education (HE) researchers conduct their research - specifically their Research Data Management (RDM) practices. New regulatory requirements, research security threats, and evolving expectations of research transparency and reproducibility warrant a new and fresh approach.

Modern clinical trials demand integrated systems to streamline workflows, centralize data, and ensure compliance. Fragmented tools slow research, increase costs, and risk errors, while platforms like myLaminin CTMS enhance efficiency, oversight, and data quality. By accelerating studies without compromising accuracy, modern clinical trial infrastructure supports faster, safer drug development and more reliable outcomes for patients.

University-led clinical trials are evolving as academic institutions adopt industry-grade infrastructure, centralized systems, and compliant data practices. Driven by growing complexity, AI, and digital health, universities are professionalizing research operations end-to-end. Platforms like myLaminin enable scalable, secure, and compliant trial execution bridging the gap between early discovery and full clinical development.

CROs have evolved into essential partners in clinical trials, offering scalability, expertise, and global reach amid rising complexity. However, fragmented systems, blurred oversight, and data silos create risk. The future lies in integrated platforms like myLaminin that connect sponsors, CROs, and sites, improving transparency, governance, and execution across decentralized research ecosystems.

Clinical research is falling behind healthcare IT due to fragmented systems, weak incentives, and lack of a true system of record. Many teams still rely on spreadsheets and disconnected tools, slowing studies and limiting collaboration. Strong clinical research data management, better governance, and connected platforms like myLaminin can help organizations improve efficiency, maintain context, and build scalable, future-ready research infrastructure.